Neoadjuvant systemic therapy for regionally advanced melanoma.

James W JakubJennifer M RaczTina J HiekenAlexandra B GonzalezLisa A KottschadeSvetomir N MarkovicYiyi YanMathew S Block

Published in: Journal of surgical oncology (2017)

Neoadjuvant systemic therapy is a reasonable approach for patients with advanced but resectable/borderline resectable disease and the risk of losing regional control is low. Our data also suggest some patients with unresectable disease will be converted to resectable and a complete clinical response to treatment can be obtained in approximately one quater of patients.

Keyphrases

locally advanced
rectal cancer
liver metastases
squamous cell carcinoma
radiation therapy
end stage renal disease
ejection fraction
newly diagnosed
lymph node
chronic kidney disease
prognostic factors
peritoneal dialysis
stem cells
deep learning
replacement therapy
data analysis
drug induced